Mechanism of Guilu Erxian Gum in the treatment of osteoporosis based on network pharmacology

• 作者: Peng Liu Dong-Xiang Yang Dong-Dong Yu Xiu-Ting Wang
• 来源期刊: 海南医科大学学报（英文版）
• 年，卷（期）: 2022,（3）
• 所属期刊栏目: Original article
• 页码范围: 49-55
• 页数: 7页
• 语种: 英文

摘要

Objective: This article uses the method of network pharmacology to study the related mechanism of Guilu Erxian Gum in the treatment of osteoporosis. Methods: Based on the TCMSP database, ETCM database, chemistry database, and DrugBank database, the potential active ingredients and related targets of Guilu Erxian Gum were obtained. The known therapeutic targets of osteoporosis were obtained from OMIM and Genecards databases, and the STRING database was used. A protein interaction network (PPI) of active ingredients-disease targets was established, and the topological parameters of the network were analyzed using Cytoscape 3.8.0 software to obtain key active ingredients and their targets. In R4.0.2, the Bioconductor data package was used to analyze the GO biological function and KEGG pathway analysis of key targets, and obtain the effective ingredients and targets of Guilu Erxian Gum for treating osteoporosis. Results: The prediction results show that Guilu Erxian Gum has 87 active ingredients and 2305 targets, and there are 4141 known therapeutic targets for osteoporosis. The two act together to obtain a total of 71 PPI core genes. The GO biological process analysis yielded 95 entries, and the KEGG pathway analysis yielded 115 pathways. Conclusion: The analysis results show that Guilu Erxian Gum may play an anti-osteoporosis effect by regulating inflammatory factors, promoting osteoblast differentiation, inhibiting osteoclast formation, and improving microcirculation. The pathways involved include TNF signaling pathways, IL-17 signaling pathway, NF-κB signaling pathway, HIF-1 signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, etc. This study provides a theoretical basis for further elucidating the pharmacological mechanism of Guilu Erxian Gum in the treatment of osteoporosis.